These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24490956)

  • 1. Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.
    Dorn J; Beaufort N; Schmitt M; Diamandis EP; Goettig P; Magdolen V
    Crit Rev Clin Lab Sci; 2014 Apr; 51(2):63-84. PubMed ID: 24490956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
    Dorn J; Harbeck N; Kates R; Magdolen V; Grass L; Soosaipillai A; Schmalfeldt B; Diamandis EP; Schmitt M
    Biol Chem; 2006 Aug; 387(8):1121-8. PubMed ID: 16895483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.
    Owen KA; Qiu D; Alves J; Schumacher AM; Kilpatrick LM; Li J; Harris JL; Ellis V
    Biochem J; 2010 Feb; 426(2):219-28. PubMed ID: 20015050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles and regulation of membrane-associated serine proteases.
    Qiu D; Owen K; Gray K; Bass R; Ellis V
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface-anchored serine proteases in cancer progression and metastasis.
    Martin CE; List K
    Cancer Metastasis Rev; 2019 Sep; 38(3):357-387. PubMed ID: 31529338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
    Zhang W; Ling D; Tan J; Zhang J; Li L
    Oncol Rep; 2013 Feb; 29(2):637-45. PubMed ID: 23174953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of proteases in prostate cancer.
    Koistinen H; Kovanen RM; Hollenberg MD; Dufour A; Radisky ES; Stenman UH; Batra J; Clements J; Hooper JD; Diamandis E; Schilling O; Rannikko A; Mirtti T
    IUBMB Life; 2023 Jun; 75(6):493-513. PubMed ID: 36598826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
    Tan OL; Whitbread AK; Clements JA; Dong Y
    Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
    Scorilas A; Mavridis K
    Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancer.
    Ruppert C; Ehrenforth S; Scharrer I; Halberstadt E
    Cancer Detect Prev; 1997; 21(5):452-9. PubMed ID: 9307848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
    Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.
    Cho JY; Chung HC; Noh SH; Roh JK; Min JS; Kim BS
    Cancer; 1997 Mar; 79(5):878-83. PubMed ID: 9041148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interdependence of kallikrein-related peptidases in proteolytic networks.
    Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
    Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
    Konecny G; Untch M; Pihan A; Kimmig R; Gropp M; Stieber P; Hepp H; Slamon D; Pegram M
    Clin Cancer Res; 2001 Jun; 7(6):1743-9. PubMed ID: 11410515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
    Masson V
    Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.
    Duffy MJ; Duggan C
    Clin Biochem; 2004 Jul; 37(7):541-8. PubMed ID: 15234235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
    Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
    J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tissue kallikrein gene family: a rich source of novel disease biomarkers.
    Diamandis EP; Yousef GM
    Expert Rev Mol Diagn; 2001 Jul; 1(2):182-90. PubMed ID: 11901813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
    Avgeris M; Mavridis K; Scorilas A
    Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.